Detalhe da pesquisa
1.
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.
Cell
; 184(7): 1821-1835.e16, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33667349
2.
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.
Cell
; 184(21): 5432-5447.e16, 2021 10 14.
Artigo
Inglês
| MEDLINE | ID: mdl-34619077
4.
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.
Nat Immunol
; 23(2): 275-286, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35102342
5.
Self-Assembling Nanoparticles Usher in a New Era of Vaccine Design.
Cell
; 176(6): 1245-1247, 2019 03 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30849370
6.
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19.
Nat Immunol
; 23(6): 865-867, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35624207
7.
Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants.
Nature
; 600(7889): 530-535, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34670266
8.
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.
Nature
; 594(7862): 253-258, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33873199
9.
High-resolution map of the Fc functions mediated by COVID-19-neutralizing antibodies.
Proc Natl Acad Sci U S A
; 121(3): e2314730121, 2024 Jan 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38198525
10.
Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesis.
Trends Immunol
; 44(6): 424-434, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37137805
11.
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody.
Proc Natl Acad Sci U S A
; 119(20): e2120976119, 2022 05 17.
Artigo
Inglês
| MEDLINE | ID: mdl-35549549
12.
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines.
Pharmacol Rev
; 74(1): 313-339, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35101964
13.
Transforming vaccine development.
Semin Immunol
; 50: 101413, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33127296
14.
Vaccinology in the post-COVID-19 era.
Proc Natl Acad Sci U S A
; 118(3)2021 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-33431690
15.
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.
Proc Natl Acad Sci U S A
; 118(36)2021 09 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34417349
16.
Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action.
Curr Top Microbiol Immunol
; 440: 31-70, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-33861374
17.
Structure of a protective epitope reveals the importance of acetylation of Neisseria meningitidis serogroup A capsular polysaccharide.
Proc Natl Acad Sci U S A
; 117(47): 29795-29802, 2020 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33158970
18.
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.
Proc Natl Acad Sci U S A
; 117(39): 24443-24449, 2020 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-32900928
19.
4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
PLoS Pathog
; 16(10): e1008882, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33007046
20.
Vaccine sprint predicted a decade ago.
Nature
; 590(7844): 36, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33531702